A panelist discusses how their institution evaluates biosimilars for formulary inclusion through a systematic review process ...

This bipartisan legislation prevents further cuts, provides a modest inflationary adjustment to help ease the cost of care, ...

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

At today's confirmation hearing, Democratic senators were skeptical of the HHS Secretary nominee Robert F. Kennedy Jr.'s ...

After several days of worry that the global AIDS program might come to abrupt end, Secretary of State Marco Rubio issued a ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid medication for treating moderate to severe acute pain in adults. Journavx, approved ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...